| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2008 | US20080221184 angiotensin II antagonist and a prostaglandin which is unoprostone or latanoprost; superior intraocular pressure lowering effect |
| 09/11/2008 | US20080221183 Anti-cancer and anti-microbial oxazolidinones |
| 09/11/2008 | US20080221182 Anti-cancer and anti-microbial oxazolidinones |
| 09/11/2008 | US20080221181 Compounds for treating tumors |
| 09/11/2008 | US20080221180 Thiazole Derivatives and Use Thereof |
| 09/11/2008 | US20080221179 SUBSTITUTED PHENOXY AMINOTHIAZOLONES as estrogen related receptor-alpha modulators |
| 09/11/2008 | US20080221178 Benzimidazole Derivatives,Compositions Containing Them, Preparation Thereof and Uses Thereof |
| 09/11/2008 | US20080221176 treatment of diabetes mellitus, cardiovascular disease, dyslipidemia, artherosclerosis, peripheral vascular disease, inflammation, cancer, and diseases of the central nervous system; 1,1,1,3,3,3-hexafluoro-2-{4-[methyl(phenylmethyl)amino]phenyl}-2-propanol |
| 09/11/2008 | US20080221175 N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases |
| 09/11/2008 | US20080221174 Controlled release nisoldipine compositions |
| 09/11/2008 | US20080221173 Having dopaminergic activity comprising trigonelline and 4-hydroxyisoleucine; extracting a clear solution containing trigonelline and 4-hydroxyisoleucine from plant source; prolactin inhibitors; decrease side-effects and sexual dysfunction caused by increased Prolactin |
| 09/11/2008 | US20080221172 Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection |
| 09/11/2008 | US20080221171 neoplastic disease, autoimmune disease, transplantation related pathology and/or degenerative disease; selectively inducing apoptosis in cancer cells |
| 09/11/2008 | US20080221170 Chronic pain, allodynia, hyperalgesia, fatigue, sleep disturbance, and depression; Central Sensitivity Syndrome; kits |
| 09/11/2008 | US20080221169 3-carboxy aryl sulfonamide compounds, which agonize or antagonize aquaporin channels; brain trauma, head trauma, eye disorder, pulmonary disorder, lung disease, vascular disease, kidney disease, heavy metal toxicity, Alzheimer's disease, tumor, and cancer |
| 09/11/2008 | US20080221166 sleep disorders; (R)-2-[(S)1-(5-chloro-2-methoxy-phenyl)-3-(6-trifluoromethyl-pyridin-3-yl)-propylamino]-2-(4-fluoro-phenyl)-N-methyl-acetamide |
| 09/11/2008 | US20080221165 Use of Octenidine Dihydrochloride in Semisolid Preparations |
| 09/11/2008 | US20080221164 Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use |
| 09/11/2008 | US20080221163 behave as estrogen antagonists in the uterus that do not stimulate the ovaries; for treating endometriosis and uterine leiomyoma; 8-Methylsulfanyl-5-[4-(2-piperidin-1-yl-ethoxy)-phenyl-5H-6-oxa-chrysen-2-ol hydrochloride |
| 09/11/2008 | US20080221162 to treat psychosomatic disorders, respiratory, allergic conditions, inflammatory conditions, cardiac conditions, gastrointestinal conditions, conditions of the urogenital system, and conditions of the cutaneous system |
| 09/11/2008 | US20080221161 treatment or prevention of metabolic, cardiovascular, and inflammatory diseases; 1-(7-methoxy-2-(thiophen-3-yl)quinolin-3-yl)-N-(4-(trifluoromethyl)benzyl)methanamine |
| 09/11/2008 | US20080221160 Sulfonylated heterocycles useful for modulation of the progesterone receptor |
| 09/11/2008 | US20080221159 Inhibitors of human immunodeficiency virus replication |
| 09/11/2008 | US20080221158 Novel 14 and 15 Membered Ring Compounds |
| 09/11/2008 | US20080221157 (2S)-2-{[(5-Methoxy-2-methyl-1H-indol-3-yl)acetyl]amino}-8-oxo-N-[2-(2-phenyl-1H-indol-3-yl)ethyl]nonanamide; treating neurodegenerative diseases, schizophrenia and stroke |
| 09/11/2008 | US20080221156 Stable formulations of ace inhibitors, and methods for preparation thereof |
| 09/11/2008 | US20080221155 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 09/11/2008 | US20080221154 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 09/11/2008 | US20080221153 N3-substituted imidazopyridine c-kit inhibitors |
| 09/11/2008 | US20080221152 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 09/11/2008 | US20080221151 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors |
| 09/11/2008 | US20080221150 Inhibit neurodegeneration caused by lysosomal and/or mitochondrial dysfunction; bafilomycin A1, bafilomycin B1 and concanamycin |
| 09/11/2008 | US20080221149 Novel 2-Heteroaryl Substituted Benzothiophenes and Benzofuranes 709 |
| 09/11/2008 | US20080221148 Compounds and methods for kinase modulation, and indications therefor |
| 09/11/2008 | US20080221147 Method of inhibiting neurotrophin-receptor binding |
| 09/11/2008 | US20080221146 Inhibit the multimerization of nucleophosmin; cancer |
| 09/11/2008 | US20080221145 Pyrroloquinoline quinone drugs for treatement of cardiac injury and methods of use thereof |
| 09/11/2008 | US20080221144 Controlled Release Formulations |
| 09/11/2008 | US20080221143 Morphine and Morphine Precursors |
| 09/11/2008 | US20080221142 useful in interfering with the life cycle of bacteria and in treating or preventing a bacterial infection |
| 09/11/2008 | US20080221141 1 1,1-(3-dimethylamino-3-phenylpentamethylene)-1,3,4,9-tetrahydropyrano[3,4-b]indole; affinity to mu -opioid receptor |
| 09/11/2008 | US20080221140 reverse transcriptase mutants which allow an obligate chain terminating nucleoside- or nucleotide phosphate to be excised from the nascent DNA strand by ATP- or pyrophosphate-mediated excision |
| 09/11/2008 | US20080221139 Novel Compounds |
| 09/11/2008 | US20080221138 Method of using SAHA and Erlotinib for treating cancer |
| 09/11/2008 | US20080221137 Sodium channel moderators; antiarrhythmia agents; analgesics; antiarthritic agents; antiinflammatory agents; antieplipetic agents; psychological disorders; nervous system disorders |
| 09/11/2008 | US20080221136 Novel Pyrrolo [3,2-D]Pyrimidin-4-One Derivatives And Their Use In Therapy |
| 09/11/2008 | US20080221135 Combination therapy |
| 09/11/2008 | US20080221134 Parkinson's disease, catalepsy, dystonia, dyskinetic syndrome, restless legs syndrome, migraine, pain, dementia, neurodegenerative disorders, alcohol withdrawal and/or ischemic conditions such as e.g. stroke or cardiac ischemia. |
| 09/11/2008 | US20080221133 Compounds |
| 09/11/2008 | US20080221132 Multi-Functional Small Molecules as Anti-Proliferative Agents |
| 09/11/2008 | US20080221131 Respiratory system disorders; asthma; chronic obstructive pulminary disease; antiproliferative agents; immunosuppressants |
| 09/11/2008 | US20080221129 New compounds |
| 09/11/2008 | US20080221128 Metalloprotease inhibitors containing a squaramide moiety |
| 09/11/2008 | US20080221127 Ppar active compounds |
| 09/11/2008 | US20080221126 N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide; and bortezomib effect apoptosis of myeloma cells; optimal precision in concentration yields efficacy without toxicity, requires a regimen based on kinetics of the active ingredients' availability to target sites |
| 09/11/2008 | US20080221125 Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 09/11/2008 | US20080221124 Cancer drug; due to high solubility of ethanolamine salt in the aqueous phase of reaction mixture, it can be separated from the organic phase with little, no loss of yield; aqueous phase can be charged to hot aqueous acetic acid to crystallize product; poorly filtering polymorphic form is not generated |
| 09/11/2008 | US20080221123 geranylgeranyltransferase I inhibitors; treatment of neoplasia, hyperproliferative cell growth, psoriasis, intimal hyperplasia (restinosis) and chronic inflammatory diseases including rheumatoid and osteoarthritis |
| 09/11/2008 | US20080221122 cancer and non-cancer diseases associated with vascular proliferation; mitoxantrone resistant, taxol resistant cancers |
| 09/11/2008 | US20080221121 Controlled release of sterile freeze dried aripirazole in water for intramuscular injection |
| 09/11/2008 | US20080221120 Identify pyrazole imine derivatives that modulate activity of aquaporin-; culturing a cell expressing an aquaporin-1 (AQP1) in the presence of an agent, determine effect on cell migration, cell adhesion, cell proliferation; treat cellular proliferative disease, cancer |
| 09/11/2008 | US20080221119 Pyrrolo-pyridine kinase modulators |
| 09/11/2008 | US20080221118 Tetrahydroquinoline Derivatives |
| 09/11/2008 | US20080221117 Analgesics; antidiabetic agents;anticancer agents;psychological disorders; schizophrenia; neurodegenerative diseases |
| 09/11/2008 | US20080221116 for the treatment of benign prostatic hypertrophy and/or lower urinary tract symptoms; with finasteride |
| 09/11/2008 | US20080221115 amino-phenyl-acetic acid octadec-(Z)-9-enyl ester HCl and piperazin-1-yl acetic acid octadec-(Z)-9-enyl ester bitartrate; topical; non-steroidal |
| 09/11/2008 | US20080221114 (S)-1-(1,3-benzoxazol-2-yl)-2-[[(S)-3-methylpiperidin-1-yl]carbonyl]indoline; for treating/preventing anxiety disorder, depression, epilepsy, dementia; can selectively act on mitochondrial benzodiazepine receptor |
| 09/11/2008 | US20080221113 Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments |
| 09/11/2008 | US20080221112 New utilities of amide compounds |
| 09/11/2008 | US20080221111 Combination of a Pd4 Inhibitor and a Tetrahydrobiopterin Derivative |
| 09/11/2008 | US20080221110 Tricyclic condensed ring nitrogen compound selectively acts on cannabinoid receptors; Gram-negative and Gram-positive bacterial infections; 1-({4-[(6,7-Dihydro[1,4]dioxino[2,3-c]pyridazin-3-ylmethyl)amino]-1-piperidinyl}methyl)-9-fluoro-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one |
| 09/11/2008 | US20080221108 Anthranilic Acid Derivatives As Hm74A Receptor Agonists |
| 09/11/2008 | US20080221107 6-(4-chlorophenyl)-3-{4-[(3R)-3-hydroxypyrrolidin-1-yl]-3-methoxyphenyl}thieno[3,2-d][1,2,3]triazin-4(3H)-one; Melanin concentrating hormone receptor antagonist; obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and neurological disorders |
| 09/11/2008 | US20080221106 Arylamine Ketones, Their Preparation Methods, The Pharmaceutical Composition Containing Them And Their Use |
| 09/11/2008 | US20080221105 1-[1-(methylsulfonyl)piperidin-4-yl]-3-(adamant-1-yl)urea, 1-[1-(acetyl)piperidin-4-yl]-3-(adamant-1-yl)urea; incipient diabetes, glucose intolerance, obesity, hypertension, high blood pressure, elevated serum cholesterol, reduced high-density lipoproteins and elevated triglyceride levels |
| 09/11/2008 | US20080221104 1-[3-(morpholine-4-carbonyl)-phenyl]-3-(4-trifluoromethyl-phenyl)-urea; reduce autoimmune cytokine levels; treat or ameliorate the symptoms associated celiac disease, Crohn's disease, inflammatory bowel disease |
| 09/11/2008 | US20080221103 4-(3-Methyl-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-ylamino)-6-(methylthio)-2-phenylpyrimidine-5-carbonitrile; having significant in vitro TNF- alpha inhibitory activity useful for the treatment of various inflammatory diseases such as arthritis, inflammatory bowel disease, psoriasis, asthma, COPD, cancer etc. |
| 09/11/2008 | US20080221102 Composition and methods for modulating a kinase cascade |
| 09/11/2008 | US20080221101 Calcium receptor modulating agents |
| 09/11/2008 | US20080221100 Soluble epoxide hydrolase inhibitors |
| 09/11/2008 | US20080221099 Dihydropteridinones for the treatment of cancer diseases |
| 09/11/2008 | US20080221098 Compounds and compositions as protein kinase inhibitors |
| 09/11/2008 | US20080221097 N-(3-Bromophenyl)-1-methyl-7-(1-piperidinylcarbonyl)-1H-imidazo[4,5-c]pyridin-4-amine hydrochloride salt; immune disorder, an inflammatory disorder, pain, rheumatoid arthritis, multiple sclerosis, osteoarthritis or osteoporosis |
| 09/11/2008 | US20080221096 Pyrido[3' ,2':4,5]Furo[3,2-d]Pyrimidine Derivatives |
| 09/11/2008 | US20080221095 increased potency and selectivity in relation to currently known MMP-13, MMP-8 and MMP-3 inhibitors; treating rheumatoid arthritis, osteoarthritis or inflammation; squaramide or benzoxazinone moiety |
| 09/11/2008 | US20080221094 Metalloprotease inhibitors containing a squaramide moiety |
| 09/11/2008 | US20080221093 Metalloprotease inhibitors containing a heterocyclic moiety |
| 09/11/2008 | US20080221092 Heterobicyclic metalloprotease inhibitors |
| 09/11/2008 | US20080221091 Metalloprotease inhibitors containing a heterocyclic moiety |
| 09/11/2008 | US20080221090 treating hepatitis C infection; 6-cyclohexyl-2,3-dihydro-5-phenyl-1,4-oxazino[2,3,4-hi]indole-9-carboxylic acid |
| 09/11/2008 | US20080221089 Compositions and methods for inhibition of the jak pathway |
| 09/11/2008 | US20080221088 3,4-Substituted Thiazoles as Ampk Activators |
| 09/11/2008 | US20080221087 Substituted lactams as inhibitors of abeta protein production |
| 09/11/2008 | US20080221086 Novel Inhibitors of Glutaminyl Cyclase |
| 09/11/2008 | US20080221085 Nicotinic Receptor Agonists for the Treatment of Inflammatory Diseases |
| 09/11/2008 | US20080221084 Method for reducing infarction using vasopressin antagonist compounds, and compositions and combinations therefor |
| 09/11/2008 | US20080221083 Heterobicyclic metalloprotease inhibitors |
| 09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
| 09/11/2008 | US20080221081 Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid s,s dioxide and methods of making and using the same |
| 09/11/2008 | US20080221080 Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias |